Main Content
Publication list of the institute from 2023
- Aksoy C. & Karschuck P. & Derigs M. & Sevinc S. & Groeben C. & Zacharis A. & Flegar L. & Pehl A. & Huber J. & Mandal S. (2023)
Successful management of 30 kg Gigantic para-testicular liposarcoma
in: BMC Urology (23)
10.1186/s12894-023-01236-3
- Alhyari A. & Görg C. & Tahat S. & Trenker C. & Dietrich C. F. & Westhoff C. C. & Safai Zadeh E. & Findeisen H. (2023)
Acoustic Radiation Force Impulse (ARFI) Elastography of Focal Splenic Lesions: Feasibility and Diagnostic Potential
in: Cancers (15)
10.3390/cancers15204964
- von Blanckenburg P. & Seifart C. & Ramaswamy A. & Berthold D. & Volberg C. (2023)
Prolonged Grief in Times of Lockdown During the COVID-19 Pandemic
in: OMEGA - Journal of Death and Dying
10.1177/00302228231182738
- Curigliano G. & Burstein H. & Gnant M. & Loibl S. & Cameron D. & Regan M. & Denkert C. & Poortmans P. & Weber W. et al. (2023)
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023
in: Annals of Oncology (34)
10.1016/j.annonc.2023.08.017
- Decker T. & Lüdtke-Heckenkamp K. & Melnichuk L. & Hirmas N. & Lübbe K. & Zahn M.-O. & Schmidt M. & Denkert C. & Lorenz R. & Müller V. & Zahm D.-M. & Mundhenke C. & Bauer S. & Thill M. & Seropian P. & Filmann N. & Loibl S. (2023)
Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)
in: The Breast (72)
10.1016/j.breast.2023.08.007
- Denkert C. & Lambertini C. & Fasching P. A. & Pogue-Geile K. L. & Mano M. S. & Untch M. & Wolmark N. & Huang C.-S. & Loibl S. & Mamounas E. P. & Geyer C. E. & Lucas P. C. & Boulet T. & Song C. & Lewis G. D. & Nowicka M. & de Haas S. & Basik M. (2023)
Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer
in: Clinical Cancer Research (29)
10.1158/1078-0432.ccr-22-1989
- Denkert C. & Lebeau A. & Schildhaus H. U. & Jackisch C. & Rüschoff J. (2022)
New treatment options for metastatic HER2-low breast cancer: Konsequenzen für die histopathologische Diagnostik
in: Die Pathologie (44)
10.1007/s00292-022-01139-4
- Döring C. & Peer K. & Bankov K. & Bollmann C. & Ramaswamy A. & Di Fazio P. & Wild P. J. & Bartsch D. K. (2023)
Whole-exome sequencing of calcitonin-producing pancreatic neuroendocrine neoplasms indicates a unique molecular signature
in: Frontiers in Oncology (13)
10.3389/fonc.2023.1160921
- Enukashvily N. I. & Ponomartsev N. V. & Ketkar A. & Suezov R. & Chubar A. V. & Prjibelski A. D. & Shafranskaya D. D. & Elmshäuser S. & Keber C. U. & Stefanova V. N. & Akopov A. L. & Klingmüller U. & Pfefferle P. I. & Stiewe T. & Lauth M. & Brichkina A. I. (2023)
Pericentromeric satellite lncRNAs are induced in cancer-associated fibroblasts and regulate their functions in lung tumorigenesis
in: Cell Death & Disease (14)
10.1038/s41419-023-05553-1
- Fasching P. A. & Szeto C. & Denkert C. & Benz S. & Weber K. & Spilman P. & Budczies J. & Schneeweiss A. & Stickeler E. & Schmatloch S. & Jackisch C. & Karn T. & Sinn H. P. & Warm M. & van Mackelenbergh M. & Rabizadeh S. & Schem C. & Heinmöller E. & Mueller V. & Marmé F. & Soon-Shiong P. & Nekljudova V. & Untch M. & Loibl S. (2023)
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
in: Clinical Cancer Research (29)
10.1158/1078-0432.ccr-22-2213
- Findeisen H. & Westhoff C. & Dietrich C. F. & Trenker C. & Alhyari A. & Safai Zadeh E. & Görg C. (2023)
Inflammatory pseudotumor of the omentum in contrast-enhanced ultrasound
in: Journal of Ultrasonography (23)
10.15557/jou.2023.0006
- Findeisen H. & Westhoff C. & Trenker C. & Görg C. & Krönig J. & Safai Zadeh E. (2023)
Pulmonary cystic echinococcosis in contrast enhanced ultrasound – a case report
in: Journal of Ultrasonography (23)
10.15557/jou.2023.0008
- Foersch S. & Glasner C. & Woerl A.-C. & Eckstein M. & Wagner D.-C. & Schulz S. & Kellers F. & Fernandez A. & Tserea K. & Kloth M. & Hartmann A. & Heintz A. & Weichert W. & Roth W. & Geppert C. & Kather J. N. & Jesinghaus M. (2023)
Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer
in: Nature Medicine (29)
10.1038/s41591-022-02134-1
- Gonçalves J. P. L. & Bollwein C. & Noske A. & Jacob A. & Jank P. & Loibl S. & Nekljudova V. & Fasching P. A. & Karn T. & Marmé F. & Müller V. & Schem C. & Sinn B. V. & Stickeler E. & van Mackelenbergh M. & Schmitt W. D. & Denkert C. & Weichert W. & Schwamborn K. (2023)
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging
in: International Journal of Molecular Sciences (24)
10.3390/ijms24032860
- Griger J. & Widholz S. A. & Jesinghaus M. & de Andrade Krätzig N. & Lange S. & Engleitner T. & Montero J. J. & Zhigalova E. & Öllinger R. & Suresh V. & Winkler W. & Lier S. & Baranov O. & Trozzo R. & Ben Khaled N. & Chakraborty S. & Yu J. & Konukiewitz B. & Steiger K. & Pfarr N. & Rajput A. & Sailer D. & Keller G. & Schirmacher P. & Röcken C. & Fagerstedt K. W. & Mayerle J. & Schmidt-Supprian M. & Schneider G. & Weichert W. & Calado D. P. & Sommermann T. & Klöppel G. & Rajewsky K. & Saur D. & Rad R. (2023)
An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets
in: Cancer Cell (41)
10.1016/j.ccell.2023.06.001
- Heitz F. & Ataseven B. & Staniczok C. & Denkert C. & Rhiem K. & Hahnen E. & Heikaus S. & Moubarak M. & Welz J. & Dagres T. & Vrentas V. & Bommert M. & Schneider S. & Concin N. & Harter P. (2023)
Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer
in: Cancers (15)
10.3390/cancers15030818
- Hiltner T. & Kohlruss M. & Herz A.-L. & Lorenzen S. & Novotny A. & Hapfelmeier A. & Jesinghaus M. & Slotta-Huspenina J. & Sisic L. & Gaida M. M. & Weichert W. & Ott K. & Keller G. (2023)
Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients
in: Journal of Cancer Research and Clinical Oncology (149)
10.1007/s00432-023-04691-5
- Hiltner T. & Szörenyi N. & Kohlruss M. & Hapfelmeier A. & Herz A.-L. & Slotta-Huspenina J. & Jesinghaus M. & Novotny A. & Lange S. & Ott K. & Weichert W. & Keller G. (2023)
Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations
in: Cancers (15)
10.3390/cancers15030771
- Hoffmann I. & Dragomir M. P. & Monjé N. & Keunecke C. & Kunze C. A. & Schallenberg S. & Marchenko S. & Schmitt W. D. & Kulbe H. & Sehouli J. & Braicu I. E. & Jank P. & Denkert C. & Darb-Esfahani S. & Horst D. & Sinn B. V. & Sers C. & Bischoff P. & Taube E. T. (2023)
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
in: Neoplasia (44)
10.1016/j.neo.2023.100934
- Huober J. & van Mackelenbergh M. & Schneeweiss A. & Seither F. & Blohmer J.-U. & Denkert C. & Tesch H. & Hanusch C. & Salat C. & Rhiem K. & Solbach C. & Fasching P. A. & Jackisch C. & Reinisch M. & Lederer B. & Mehta K. & Link T. & Nekljudova V. & Loibl S. & Untch M. (2023)
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy
in: npj Breast Cancer (9)
10.1038/s41523-023-00525-2
- Irqsusi M. & Gerlach S. v. & Rastan A. J. & Ghazy T. (2023)
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
in: The Thoracic and Cardiovascular Surgeon Reports (12)
10.1055/s-0043-1764473
- Jank P. & Leichsenring J. & Kolb S. & Hoffmann I. & Bischoff P. & Kunze C. A. & Dragomir M. P. & Gleitsmann M. & Jesinghaus M. & Schmitt W. D. & Kulbe H. & Sers C. & Stenzinger A. & Sehouli J. & Braicu I. E. & Westhoff C. & Horst D. & Denkert C. & Gröschel S. & Taube E. T. (2023)
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
in: Journal of Ovarian Research (16)
10.1186/s13048-023-01239-6
- Kaidar-Person O. & Pfob A. & Gentilini O. D. & Borisch B. & Bosch A. & Cardoso M. J. & Curigliano G. & De Boniface J. & Denkert C. & Hauser N. & Heil J. & Knauer M. & Kühn T. & Lee H.-B. & Loibl S. & Mannhart M. & Meattini I. & Montagna G. & Pinker K. & Poulakaki F. & Rubio I. T. & Sager P. & Steyerova P. & Tausch C. & Tramm T. & Vrancken Peeters M.-J. & Wyld L. & Yu J. H. & Weber W. P. & Poortmans P. & Dubsky P. (2023)
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus
in: eClinicalMedicine (61)
10.1016/j.eclinm.2023.102085
- Kohlruss M. & Chakraborty S. & Hapfelmeier A. & Jesinghaus M. & Slotta-Huspenina J. & Novotny A. & Sisic L. & Gaida M. M. & Ott K. & Weichert W. & Pfarr N. & Keller G. (2023)
Low microsatellite instability: A distinct instability type in gastric cancer?
in: Journal of Cancer Research and Clinical Oncology (149)
10.1007/s00432-023-05430-6
- Kolb S. & Hoffmann I. & Monjé N. & Dragomir M. P. & Jank P. & Bischoff P. & Keunecke C. & Pohl J. & Kunze C. A. & Marchenko S. & Schmitt W. D. & Kulbe H. & Sers C. & Sehouli J. & Braicu E. I. & Denkert C. & Darb-Esfahani S. & Horst D. & Sinn B. V. & Taube E. T. (2023)
LRP1B—a prognostic marker in tubo-ovarian high-grade serous carcinoma
in: Human Pathology (141)
10.1016/j.humpath.2023.09.001
- Kroenig J. & Safai Zadeh E. & Westhoff C. C. & Klemmer A. & Alhyari A. & Görg C. (2022)
Diagnosis of Thoracic Splenosis by Contrast-Enhanced Ultrasound (CEUS)
in: Ultraschall in der Medizin - European Journal of Ultrasound (44)
10.1055/a-1926-7142
- Lang-Schwarz C. & Büttner-Herold M. & Burian S. & Erber R. & Hartmann A. & Jesinghaus M. & Kamarádová K. & Rubio C. A. & Seitz G. & Sterlacci W. & Vieth M. & Bertz S. (2023)
Morphological subtypes of colorectal low-grade intraepithelial neoplasia: diagnostic reproducibility, frequency and clinical impact
in: Journal of Clinical Pathology
10.1136/jcp-2023-209206
- Link T. & Blohmer J.-U. & Schmitt W. D. & Kuhlmann J. D. & Just M. & Untch M. & Stotzer O. & Fasching P. A. & Thill M. & Reinisch M. & Schneeweiss A. & Wimberger P. & Seiler S. & Huober J. & Jackisch C. & Rhiem K. & Hanusch C. & Sinn B. V. & Nekljudova V. & Loibl S. & Denkert C. (2023)
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial
in: Clinical Cancer Research (29)
10.1158/1078-0432.ccr-23-1801
- Litmeyer A. & Konukiewitz B. & Kasajima A. & Foersch S. & Schicktanz F. & Schmitt M. & Kellers F. & Grass A. & Jank P. & Lehman B. & Gress T. M. & Rinke A. & Bartsch D. K. & Denkert C. & Weichert W. & Klöppel G. & Jesinghaus M. (2023)
High expression of insulinoma‐associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin
in: The Journal of Pathology: Clinical Research (9)
10.1002/cjp2.339
- Litton J. K. & Regan M. M. & Pusztai L. & Rugo H. S. & Tolaney S. M. & Garrett-Mayer E. & Amiri-Kordestani L. & Basho R. K. & Best A. F. & Boileau J.-F. & Denkert C. & Foster J. C. & Harbeck N. & Jacene H. A. & King T. A. & Mason G. & O’Sullivan C. C. & Prowell T. M. & Richardson A. L. & Sepulveda K. A. & Smith M. L. & Tjoe J. A. & Turashvili G. & Woodward W. A. & Butler L. P. & Schwartz E. I. & Korde L. A. (2023)
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP
in: Journal of Clinical Oncology (41)
10.1200/jco.23.00435
- Loibl S. & Azim H. & Bachelot T. & Berveiller P. & Bosch A. & Cardonick E. & Denkert C. & Halaska M. & Hoeltzenbein M. & Johansson A. & Maggen C. & Markert U. & Peccatori F. & Poortmans P. & Saloustros E. & Saura C. & Schmid P. & Stamatakis E. & van den Heuvel-Eibrink M. & van Gerwen M. & Vandecaveye V. & Pentheroudakis G. & Curigliano G. & Amant F. (2023)
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)
in: Annals of Oncology (34)
10.1016/j.annonc.2023.08.001
- Lutz V. & Hellmund V. M. & Picard F. S. & Raifer H. & Ruckenbrod T. & Klein M. & Bopp T. & Savai R. & Duewell P. & Keber C. U. & Weigert A. & Chung H.-R. & Buchholz M. & Menke A. & Gress T. M. & Huber M. & Bauer C. (2023)
IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model
in: Cancer Immunology Research (11)
10.1158/2326-6066.cir-22-0398
- van Mackelenbergh M. T. & Loibl S. & Untch M. & Buyse M. & Geyer C. E. & Gianni L. & Schneeweiss A. & Conte P. & Piccart M. & Bonnefoi H. & Jackisch C. & Nekljudova V. & Tang G. & Valagussa P. & Neate C. & Gelber R. & Poncet C. & Squifflet P. & Saad E. D. & Heinzmann D. & Denkert C. & Rastogi P. & Cortes J. & Guarneri V. & de Azambuja E. & Cameron D. & Ismael G. & Wolmark N. & Cortazar P. (2023)
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer
in: Journal of Clinical Oncology (41)
10.1200/jco.22.02241
- Marchenko S. & Piwonski I. & Hoffmann I. & Sinn B. V. & Kunze C. A. & Monjé N. & Pohl J. & Kulbe H. & Schmitt W. D. & Darb-Esfahani S. & Braicu E. I. & von Brünneck A.-C. & Sehouli J. & Denkert C. & Horst D. & Jöhrens K. & Taube E. T. (2022)
Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma
in: Journal of Cancer Research and Clinical Oncology (149)
10.1007/s00432-022-04101-2
- Marmé F. & Krieghoff-Henning E. & Gerber B. & Schmitt M. & Zahm D.-M. & Bauerschlag D. & Forstbauer H. & Hildebrandt G. & Ataseven B. & Brodkorb T. & Denkert C. & Stachs A. & Krug D. & Heil J. & Golatta M. & Kühn T. & Nekljudova V. & Gaiser T. & Schönmehl R. & Brochhausen C. & Loibl S. & Reimer T. & Brinker T. J. (2023)
Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images
in: European Journal of Cancer (195)
10.1016/j.ejca.2023.113390
- Martin E. & Görg C. & Pehl A. & Safai Zadeh E. (2022)
B-Mode Ultrasound Patterns of Systemic Silicone Disease
in: Ultraschall in der Medizin - European Journal of Ultrasound (44)
10.1055/a-1816-6236
- Page D. B. & Broeckx G. & Jahangir C. A. & Verbandt S. & Gupta R. R. & Thagaard J. & Khiroya R. & Kos Z. & Abduljabbar K. et al. (2023)
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
in: The Journal of Pathology (260)
10.1002/path.6165
- Paul M. C. & Schneeweis C. & Falcomatà C. & Shan C. & Rossmeisl D. & Koutsouli S. & Klement C. & Zukowska M. & Widholz S. A. & Jesinghaus M. & Heuermann K. K. & Engleitner T. & Seidler B. & Sleiman K. & Steiger K. & Tschurtschenthaler M. & Walter B. & Weidemann S. A. & Pietsch R. & Schnieke A. & Schmid R. M. & Robles M. S. & Andrieux G. & Boerries M. & Rad R. & Schneider G. & Saur D. (2023)
Non-canonical functions of SNAIL drive context-specific cancer progression
in: Nature Communications (14)
10.1038/s41467-023-36505-0
- Rehder H. & Kircher S. G. & Schoner K. & Smogavec M. & Behunova J. & Ihm U. & Plassmann M. & Hofer M. & Ringl H. & Laccone F. (2023)
Brain malformations in diprosopia observed in clinical cases, museum specimens and artistic representations
in: Orphanet Journal of Rare Diseases (18)
10.1186/s13023-023-02617-5
- Riecke K. & Müller V. & Neunhöffer T. & Park-Simon T.-W. & Weide R. & Polasik A. & Schmidt M. & Puppe J. & Mundhenke C. & Lübbe K. & Hesse T. & Thill M. & Wuerstlein R. & Denkert C. & Decker T. & Fehm T. & Nekljudova V. & Rey J. & Loibl S. & Laakmann E. & Witzel I. (2023)
Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry
in: ESMO Open (8)
10.1016/j.esmoop.2023.101213
- Rodepeter F. R. & Teply-Szymanski J. & Romey M. & Grass A. & Erber R. & Lebeau A. & Mack E. K. M. & Tarawneh T. S. & Gremke N. & Boekhoff J. & Wündisch T. & Wagner U. & Jank P. & Denkert C. (2023)
Klinisch relevante molekularpathologische Diagnostik beim Mammakarzinom
in: Die Pathologie (44)
10.1007/s00292-022-01175-0
- Schinner J. & Cunha T. & Mayer J. U. & Hörster S. & Kind P. & Didona D. & Keber C. & Hertl M. & Worzfeld T. & Juratli H. A. (2023)
Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris
in: Frontiers in Immunology (14)
10.3389/fimmu.2023.1203776
- Schult D. & Maurer H. C. & Frolova M. & Ringelhan M. & Mayr U. & Ulrich J. & Heilmaier M. & Rasch S. & Lahmer T. & Reitmeier S. & Hennig C. & Gassner C. & Thur N. & Will T. & Janssen K.-P. & Steiger K. & Jesinghaus M. & Neuhaus K. & Quante M. & Haller D. & Abdelhafez M. & Schmid R. M. & Middelhoff M. (2023)
Systematic Evaluation of Clinical, Nutritional, and Fecal Microbial Factors for Their Association With Colorectal Polyps
in: Clinical and Translational Gastroenterology (15)
10.14309/ctg.0000000000000660
- Schulz S. & Jesinghaus M. & Foersch S. (2023)
Multistain Deep Learning zur Vorhersage von Prognose und Therapieansprechen im kolorektalen Karzinom
in: Die Pathologie (44)
10.1007/s00292-023-01280-8
- Sivakumar S. & Lieber S. & Librizzi D. & Keber C. & Sommerfeld L. & Finkernagel F. & Roth K. & Reinartz S. & Bartsch J. W. & Graumann J. & Müller‐Brüsselbach S. & Müller R. (2023)
Basal cell adhesion molecule promotes metastasis‐associated processes in ovarian cancer
in: Clinical and Translational Medicine (13)
10.1002/ctm2.1176
- Squifflet P. & Saad E. D. & Loibl S. & van Mackelenbergh M. T. & Untch M. & Rastogi P. & Gianni L. & Schneeweiss A. & Conte P. & Piccart M. & Bonnefoi H. & Jackisch C. & Nekljudova V. & Tang G. & Valagussa P. & Neate C. & Gelber R. & Poncet C. & Heinzmann D. & Denkert C. & Geyer C. E. & Cortes J. & Guarneri V. & de Azambuja E. & Cameron D. & Ismael G. & Wolmark N. & Cortazar P. & Buyse M. (2023)
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2–Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti–Human Epidermal Growth Factor Receptor 2 Therapy
in: Journal of Clinical Oncology (41)
10.1200/jco.22.02363
- Stark M. & Nicolai M. & Tatura M. & Keber C. U. & Kaufmann A. & Chung H. & Slater E. P. & Heeschen C. & Lawlor R. T. & Scarpa A. & Bartsch D. K. & Gress T. M. & Bauer S. & Buchholz M. (2023)
Dissecting the role of toll‐like receptor 7 in pancreatic cancer
in: Cancer Medicine (12)
10.1002/cam4.5606
- Steitz A. M. & Schröder C. & Knuth I. & Keber C. U. & Sommerfeld L. & Finkernagel F. & Jansen J. M. & Wagner U. & Müller-Brüsselbach S. & Worzfeld T. & Huber M. & Beutgen V. M. & Graumann J. & Pogge von Strandmann E. & Müller R. & Reinartz S. (2023)
TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion
in: iScience (26)
10.1016/j.isci.2023.108401
- Stögbauer F. & Beck S. & Ourailidis I. & Hess J. & Poremba C. & Lauterbach M. & Wollenberg B. & Buchberger A. M. S. & Jesinghaus M. & Schirmacher P. & Stenzinger A. & Weichert W. & Boxberg M. & Budczies J. (2023)
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
in: British Journal of Cancer (128)
10.1038/s41416-023-02240-y
- Stögbauer F. & Geß B. & Brambs C. & Lautizi M. & Kacprowski T. & Ourailidis I. & Bronger H. & Kiechle M. & Noske A. & Keller G. & Jesinghaus M. & Poremba C. & Weichert W. & Boxberg M. (2023)
Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients
in: Cancers (15)
10.3390/cancers15153832
- Takahashi M. & Cortés J. & Dent R. & Pusztai L. & McArthur H. & Kümmel S. & Denkert C. & Park Y. H. & Im S.-A. & Ahn J.-H. & Mukai H. & Huang C.-S. & Chen S.-C. & Kim M. H. & Jia L. & Li X. T. & Tryfonidis K. & Karantza V. & Iwata H. & Schmid P. (2023)
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
in: JAMA Network Open (6)
10.1001/jamanetworkopen.2023.42107
- Tarantino P. & Viale G. & Press M. & Hu X. & Penault-Llorca F. & Bardia A. & Batistatou A. & Burstein H. & Carey L. & Cortes J. & Denkert C. & Diéras V. & Jacot W. & Koutras A. & Lebeau A. & Loibl S. & Modi S. & Mosele M. & Provenzano E. & Pruneri G. & Reis-Filho J. & Rojo F. & Salgado R. & Schmid P. & Schnitt S. & Tolaney S. & Trapani D. & Vincent-Salomon A. & Wolff A. & Pentheroudakis G. & André F. & Curigliano G. (2023)
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
in: Annals of Oncology (34)
10.1016/j.annonc.2023.05.008
- Thagaard J. & Broeckx G. & Page D. B. & Jahangir C. A. & Verbandt S. & Kos Z. & Gupta R. & Khiroya R. & Abduljabbar K. et al. (2023)
Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
in: The Journal of Pathology (260)
10.1002/path.6155
- Ulrich J. D. & Rechberger P. & Bachmann J. & Herner A. & v. Figura G. & Lahmer T. & Phillip V. & Mayr U. & Haller B. & Jesinghaus M. & Schmid R. M. & Abdelhafez M. & Schlag C. (2023)
Efficacy and Safety of Cold Snare Polypectomy of Colorectal Polyps 10–15 mm with a Hybrid Snare: A Prospective Observational Pilot Study
in: Digestion (104)
10.1159/000530642
- Untch M. & Banys-Paluchowski M. & Brucker S. Y. & Budach W. & Denkert C. & Ditsch N. & Fasching P. A. & Haidinger R. & Heil J. & Jackisch C. & Janni W. & Kolberg H.-C. & Krug D. & Loibl S. & Lüftner D. & van Mackelenbergh M. & Radosa J. C. & Reimer T. & Welslau M. & Würstlein R. & Harbeck N. & Huober J. (2023)
Treatment of Early Breast Cancer: The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations
in: Geburtshilfe und Frauenheilkunde (83)
10.1055/a-2121-2495
- Virassamy B. & Caramia F. & Savas P. & Sant S. & Wang J. & Christo S. N. & Byrne A. & Clarke K. & Brown E. & Teo Z. L. & von Scheidt B. & Freestone D. & Gandolfo L. C. & Weber K. & Teply-Szymanski J. & Li R. & Luen S. J. & Denkert C. & Loibl S. & Lucas O. & Swanton C. & Speed T. P. & Darcy P. K. & Neeson P. J. & Mackay L. K. & Loi S. (2023)
Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer
in: Cancer Cell (41)
10.1016/j.ccell.2023.01.004
- Wächter S. & Knauff F. & Roth S. & Keber C. & Holzer K. & Manoharan J. & Maurer E. & Bartsch D. K. & Di Fazio P. (2023)
Synergic Induction of Autophagic Cell Death in Anaplastic Thyroid Carcinoma
in: Cancer Investigation (41)
10.1080/07357907.2023.2183027
- Westhoff C. C. & Müller S. K. & Jank P. & Kalder M. & Moll R. (2023)
Nodal lymphangiogenesis and immunophenotypic variations of sinus endothelium in sentinel and non-sentinel lymph nodes of invasive breast carcinoma
in: PLOS ONE (18)
10.1371/journal.pone.0280936
- Westhoff C. C. & Ramaswamy A. & Kalder M. & Lebeau A. & Sinn P. & Denkert C. (2022)
Immunhistologie in der Mammadiagnostik: Strategien für effiziente Diagnostik
in: Die Pathologie (44)
10.1007/s00292-022-01174-1
- Williams T. M. & Schneeweiss A. & Jackisch C. & Shen C. & Weber K. E. & Fasching P. A. & Denkert C. & Furlanetto J. & Heinmöller E. & Schmatloch S. & Karn T. & Szeto C. W. & van Mackelenbergh M. T. & Nekljudova V. & Stickeler E. & Soon-Shiong P. & Schem C. & Mairinger T. & Müller V. & Marme F. & Untch M. & Loibl S. (2023)
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial
in: Clinical Cancer Research (29)
10.1158/1078-0432.ccr-23-0362
- Wimberger P. & Blohmer J.-U. & Krabisch P. & Link T. & Just M. & Sinn B. V. & Simon E. & Solbach C. & Fehm T. & Denkert C. & Kühn C. & Rhiem K. & Tesch H. & Kümmel S. & Petzold A. & Stötzer O. & Meisel C. & Kuhlmann J. D. & Nekljudova V. & Loibl S. (2023)
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy
in: Breast Cancer Research (25)
10.1186/s13058-023-01619-2